Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Letrozole effects in women with early-stage breast cancer reported
September 29th, 2005
Scientists report the effect of letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen in a recent issue of Clinical Cancer Research. In a recent report, researchers in the United States conducted a study "to present the basis of the decision of the Food and Drug Administration (FDA) to grant accelerated approval for letrozole for extended adjuvant treatment of early-stage breast cancer in postmenopausal women after completion of adjuvant tamoxifen. The FDA reviewed the data from the MA17 trial, a single, multinational, randomized, double-blind, and...
Source: Women's Health Weekly (2005-09-29)
|
